Marianne de Backer, Chief Executive Officer at Vir Biotechnology, Inc. (VIR), sold 38,078 shares at $7.45 ($284K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Open-market sale of $284k VIR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.45 | 19,039 | $142K | 50.0% |
| 2 | $7.45 | 19,039 | $142K | 50.0% |
| Total | $7.45 avg | 38,078 | $284K | 100% |
| Filing → |
| VIR | SELL | 2025-04-04 | $949K | — | Filing → |
| VIR | SELL | 2025-02-25 | $305K | — | Filing → |
| VIR | SELL | 2024-04-04 | $1.4M | — | Filing → |